Skip to content

Inuit and Cold Exposure

Metabolic Effects of Short-term Cold Exposure Among Greenlanders and Non-Greenlanders

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05884177
Acronym
ICE
Enrollment
25
Registered
2023-06-01
Start date
2023-09-18
Completion date
2025-12-31
Last updated
2023-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Brown Adipose Tissue

Brief summary

Brown adipose tissue (BAT) produces heat through non-shivering thermogenesis. It is activated by cold exposure, and when activated it utilizes fatty acids and glucose in order to produce heat. The tissue is especially present in newborns, who not yet have gained a layer of insulating fat to protect from heat loss, and not yet have gained much muscle to produce heat through shivering thermogenesis. It was long thought that BAT mass hereafter would retract. Modern imaging tools have proved that BAT is persistent and active in some adults. The presence and activity of BAT is negatively correlated with obesity and obesity-related metabolic disorders. The tissue retracts with advancing age and increasing BMI, and it is sensitive to environmental factors, such as diet, weather and climate. The key to activating BAT in subjects that have lost it remains elusive. BAT is activated to produce heat when exposed to cold. Populations that are most cold exposed include people living in the Arctic. It is known that people of Arctic origin such as indigenous Inuit and indigenous Siberians have genetically adapted to and are acclimatized to the cold through several genetic changes, and possibly by upregulating BAT depots and activity. The investigators aim to dig deeper into the activation mechanisms in BAT, by investigating BAT mass and activity in Greenlanders and non-Greenlanders by use of stage-of-the-art modern techniques.

Detailed description

Several studies have examined the function of brown adipose tissue (BAT), which is an important source of non-shivering thermogenesis. It has gained attention as a potential target for combating obesity. BAT has a distinct influence on glucose and triglyceride clearance, and insulin sensitivity, and it has a negative correlation with cardiometabolic risk markers. BAT activity is correlated with cold temperatures. Observational studies in Greenland are consistent with raised consumption of thyroid hormone and higher thyroid hormone turnover in cold-exposed Inuit compared to Inuit with some and limited cold exposure. However, these are indirect data that merely suggest the presence of BAT. The presence of active BAT directly illustrated by using an individualized cooling protocol and FDG-PET/CT-scan raises interest in the origin and characterization of intermediate adipose cells (beige adipose tissue) from the white adipose tissue. Based on the strong correlation between BAT and cardiometabolic health and the evolutionary pressure on Inuit to handle cold environments, the investigators will measure the cold-induced BAT activity and white fat differentiation and assess a connection with genetic and physiological characteristics ot add insight into the biology and regulation of BAT in relation to fat depots in humans. Participants of Danish and Greenlandic origin will be included for a focus on visualizing brown adipose tissue by use of PET/CT-scans before and after short term cold exposure. Additional sampling includes subcutaneous fat biopsies, blood samples, blood pressure, pulse, temperature of the skin and core, and IRT.

Interventions

OTHERShort-term cold exposure

Short-term cold exposure

Sponsors

University of Copenhagen
CollaboratorOTHER
Greenland University
CollaboratorUNKNOWN
Stig Andersen
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Ability to give informed consent * Ability to follow written and verbal instructions

Exclusion criteria

* Pregnancy and breastfeeding * Alpha- or beta-adrenergic affecting medication. * Thyroid dysfunction * Liver or kidney disease * Treatment for diabetes * MODY and TBC1D4 * Treatment of obesity * Cardiovascular disease * Cancer within 3 years * Mb Renaud * Hospitalisation for psychiatric disease * Antipsychotic medication * Drug abuse within 1-year * Alcohol abuse * Plasma glucose \> 11 mM * BMI \>35 kg/m2 * Winter swimmer

Design outcomes

Primary

MeasureTime frameDescription
BAT detectionThrough study completion, analysis for an average of 1 yearBAT mass in the cervical-upper thoracic, abdominal, and paravertebral regions at room temperature and following short-term cold exposure. BAT mass on PET/CT scans will be quantified by the degree of glucose uptake: Maximum standard unit value (SUVmax)

Secondary

MeasureTime frameDescription
Temperature of the core and at the skin on multiple sitesThrough study completion, analysis for an average of 1 yearTemperature of the core and at the skin on multiple sites. Core temperature measured with rectal thermometer. Skin temperatures measured with skin thermometer probes and infrared thermography (IRT).
Changes in thyroid functionThrough study completion, analysis for an average of 1 yearChanges in thyroid function as measured by plasma TT3, TT4 and TSH
Changes in metabolitesThrough study completion, analysis for an average of 1 yearChanges in metabolites: Plasma glucose, acylcarnitine and triglycerides
Insulin sensitivityThrough study completion, analysis for an average of 1 yearInsulin sensitivity
Adipose tissue compositionThrough study completion, analysis for an average of 1 yearSubcutaneous fat biopsies will be examined in relation to white adipose tissue (WAT) function and presence of beige adipocytes

Countries

Denmark

Contacts

Primary ContactMette MM Jensen, MD
mette.malene@rn.dk+4597660000
Backup ContactStig Andersen, MD, PhD
lasa@rn.dk+4597660000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026